Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Siying Qu"'
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Sepsis is a life-threatening condition caused by an excessive inflammatory response to an infection, associated with high mortality. However, the regulatory mechanism of sepsis remains unclear. Results In this study, bioinformatic
Externí odkaz:
https://doaj.org/article/06976617f6ad4f46b28c9a82e4017e59
Autor:
Kang Chen, Xingyu Li, Yuqi Shang, Daxiang Chen, Siying Qu, Jinxian Shu, Mei Zhang, Zhiying Wang, Jinmei Huang, Minhao Wu, Siqi Ming, Yongjian Wu
Publikováno v:
Heliyon, Vol 9, Iss 10, Pp e20806- (2023)
Background: Systemic Lupus Erythematosus (SLE) is a prototypic autoimmune disease, which is accompanied by liver damage. However, it remains unknown whether liver damage is associated with SLE progression. Method: ology: HepG2 and L-02 cells were sti
Externí odkaz:
https://doaj.org/article/3dee903ebb784cc5a12b6589e4df69cf
Autor:
Mingqi Tu, Xiaoting Wu, Siying Qu, Junyan Jin, Nisang Chen, Sangsang Xiong, Shuangyi Pei, Xinwei Li, Yan Shi, Hantong Hu, Xiaoyu Li, Jianqiao Fang, Xiaomei Shao
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
BackgroundAntidepressants still have some side effects in treating major depressive disorder (MDD), and acupuncture therapy is a complementary therapy of research interest for MDD. Acupoints are sensitive sites for disease response and stimulation po
Externí odkaz:
https://doaj.org/article/9927001e4fc44205a6fd96810a3d6655
Autor:
Xiaoting Wu, Mingqi Tu, Nisang Chen, Jiajia Yang, Junyan Jin, Siying Qu, Sangsang Xiong, Zhijian Cao, Maosheng Xu, Shuangyi Pei, Hantong Hu, Yinyan Ge, Jianqiao Fang, Xiaomei Shao
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
BackgroundMajor depressive disorder (MDD) has emerged as the fifth leading cause of years lived with disability, with a high prevalent, affecting nearly 4% of the global population. While available evidence suggests that intradermal acupuncture may e
Externí odkaz:
https://doaj.org/article/8e20fb0f456c4d8db7a6ab1a60361ecb
Autor:
Xi Wang, Wantong Zhai, Jiahui Zhu, Wei Zhao, Xiaoyi Zou, Siying Qu, Shenyue Wang, Zhongze He, Zhaoying Li, Lingyang Wang, Bo Sun, Hulun Li
Publikováno v:
Stem Cell Research & Therapy, Vol 10, Iss 1, Pp 1-11 (2019)
Abstract Introduction Multiple sclerosis (MS) is one of the most common autoimmune diseases of the central nervous system (CNS). CNS has its own unique structural and functional features, while the lack of precision regulatory element with high speci
Externí odkaz:
https://doaj.org/article/409d718db54c4e68a8cce082fa4ca81f
Publikováno v:
Biological and Pharmaceutical Bulletin. 44:976-983
Pyoluteorin is a natural occurring antibiotic and its anti-tumor activity has rarely been reported. This study aims to investigate the anti-tumor effects of pyoluteorin on human non-small cell lung cancer (NSCLC) cells. The cell proliferation was mea
Autor:
Siying Qu, Hanzhi Wang, Qunqi Hu, Yiqi Ma, Yurong Kang, Liqian Ma, Xiang Li, Luhang Chen, Boyu Liu, Xiaomei Shao, Boyi Liu, Junying Du, Yi Liang, Hongli Zhao, Yongliang Jiang, Jianqiao Fang, Xiaofen He
Management of diabetic neuropathic pain (DNP), a prevalent, refractory diabetic complication, remains a challenge. Previous research evidences have implicated microglia P2X4 receptor (P2X4R) in occurrence and development of DNP. To date, however, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::392a137774b8a5da0f83bcada4b471b5
https://doi.org/10.21203/rs.3.rs-1613857/v1
https://doi.org/10.21203/rs.3.rs-1613857/v1
Publikováno v:
Advanced Biology. :2200265
Autor:
Xueyu Fei, Jianqiao Fang, Siying Qu, Zhao-xia Tai, Hanzhi Wang, Qunqi Hu, Yongliang Jiang, Luhang Chen, Xiaofen He
Publikováno v:
Purinergic Signalling
Diabetic neuropathic pain (DNP) is a troublesome diabetes complication all over the world. P2X3 receptor (P2X3R), a purinergic receptor from dorsal root ganglion (DRG), has important roles in neuropathic pain pathology and nociceptive sensations. Her
Publikováno v:
Biologicalpharmaceutical bulletin. 44(7)
The RAS protein activator like 2 (Rasal2) has been reported to be a tumor suppressor in variety of cancers; while an oncogenic protein in ovarian cancer and triple negative breast cancer (TNBC). However, the exact role of Rasal2 in non-small cell lun